Russian Clinical Trial of Mesenchymal Cells in Patients With Septic Shock and Severe Neutropenia

NCT01849237 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

30

Enrollment

NETWORK

Sponsor class

Conditions

Septic Shock
Nonchemotherapy Drug-induced Neutropenia
Neutropenia After Chemotherapy in Oncohematological Patients
Neutropenia in Patients With Aplastic Anemia

Interventions

GENETIC: Mesenchymal stromal cells
DRUG: Standard therapy of septic shock

Sponsor

National Research Center for Hematology, Russia